• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC. CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC. CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER Back to Search Results
Model Number D138502
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cardiac Tamponade (2226)
Event Date 08/19/2020
Event Type  Injury  
Manufacturer Narrative
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Investigation is in progress, once completed a supplemental will be submitted.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a female patient ((b)(6)year old, (b)(6) lb) underwent atrial fibrillation (afib) ablation procedure with carto vizigo¿ 8.5f bi-directional guiding sheath - medium and suffered cardiac tamponade requiring pericardiocentesis.It was reported during an atrial fibrillation case, a pericardial effusion was noticed.Event discovered during use of biosense webster products after transseptal while exchanging sheaths.The physician wasn't sure what happened, they exchanged the transseptal sheath (sl1, abbott) to a vizigo and noticed the sheath was through the top of the map that was made.The physician commented they didn't feel any resistance with moving the sheath.The patient had fully recovered (no residual effects) after 2 extra days in intensive care unit (icu).The pericardial effusion was confirmed by intracardiac echo (ice).Caller reported that the medical intervention provided was a pericardiocentesis and 800 cc of fluid was removed.No ablation was performed before effusion was noticed.Irrigated catheter wasn't used at this point in the procedure.Ablation catheter wasn't inserted.No error messages were observed on biosense webster equipment during the procedure.The event is conservatively being reported under the vizigo sheath.
 
Manufacturer Narrative
It was reported that a female patient (65 year old, 160lb) underwent atrial fibrillation (afib) ablation procedure with carto vizigo¿ 8.5f bi-directional guiding sheath - medium and suffered cardiac tamponade requiring pericardiocentesis.It was reported during an atrial fibrillation case, a pericardial effusion was noticed.Event discovered during use of biosense webster products after transseptal while exchanging sheaths.The physician wasn't sure what happened, they exchanged the transseptal sheath (sl1, abbott) to a vizigo and noticed the sheath was through the top of the map that was made.The physician commented they didn¿t feel any resistance with moving the sheath.The patient had fully recovered (no residual effects) after 2 extra days in intensive care unit (icu).No ablation was performed before effusion was noticed.Irrigated catheter wasn't used at this point in the procedure.Ablation catheter wasn't inserted.No error messages were observed on biosense webster equipment during the procedure.The event is conservatively being reported under the vizigo sheath.Device investigation details: the device investigation has been completed which included a manufacturing record evaluation (mre).The manufacturing record evaluation performed for the finished device with lot number 00001328 identified no internal actions related to the reported complaint condition.Still no device has been received for analysis, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Based on the completed mre, the h4.Device manufacture date has been populated with 5/20/2020.H6.Component code of ¿g07002¿ (appropriate term/code not available) was used to represent no findings available (c20) because device not returned.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC.
33 technology drive
irvine CA 92618
MDR Report Key10552418
MDR Text Key207534199
Report Number2029046-2020-01299
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/20/2021
Device Model NumberD138502
Device Catalogue NumberD138502
Device Lot Number00001328
Was Device Available for Evaluation? No
Date Manufacturer Received12/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ABBOTT SL1 TRANSSEPTAL NEEDLE; THMCL SMTCH SF UNID, TC, F; ABBOTT SL1 TRANSSEPTAL NEEDLE; THMCL SMTCH SF UNID, TC, F
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age65 YR
Patient Weight73
-
-